H19 and metastatic neoplasm: Zhang et al. [59] found that lncRNA H19 expression was significantly upregulated in primary and metastatic tumors and correlated with poor prognosis in CRC, suggesting that H19 may be a potential biomarker to predict prognosis as well as a therapeutic strategy for CRC.